ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Predetermined Change Control Plans in March 2026. Updated March 5.
A roundup of FDA’s actions in March 2026.
FDA Output, March 2026
×
